ÆGIS Microbe Shield prevention tactics transcend the reduction of risks of nosocomial infection

PRLog (Press Release) – Feb 10, 2008 – Technology that Inhibits microbial growth on treated surface

The active ingredient in ÆGIS Microbe Shield forms a colorless, odorless, positively charged polymer that chemically bonds to the treated surface. You could think of it as a layer of electrically charged swords. When a microorganism comes in contact with the treated surface, the quaternary amine “sword” punctures the cell membrane and the electrical charge “shocks” the cell. Since nothing is transferred to the now dead cell, the antimicrobial doesn’t lose strength and the “sword” is ready for the next cell to contact it.

The benefits of the ÆGIS Microbe Shield Program prevention and remediation tactics transcend the reduction of risks of nosocomial infections to:

•   Savings in material and labor costs associated with the operation of the building;
•   Energy savings;
•   The best possible facility for the health and safety of the staff;
•   Quicker positive outcomes for the patients;
•   Marketing Value for Medical Tourism;

•   Complimenting Values for:
o   Nursing Staff
o   Maintenance Staff
o   Environmental Services Staff
o   State of the Art Equipment

A healthy clean environment starts at the micro level. Micro organisms do not germinate in the air, it need a receptive surface to grow. Source control is the key to reducing nosocomial infection in a hospital setting.

ÆGIS value add in supplementing your existing efforts in infection control and providing front line defense mechanisms


Aegis treatment in many hospitals have shown sucessful results in reducing the microbial activity without causing any harm to humans & the environments.

For more information on Aegis, please visit http://www.aegisasia.com

Tests from iaq consultants Singapore ( http://www.iaqsg.com)  has proven that aegis treatment not only reduce the microbial activity in treated surfaces, but inhibits the growth continuously for a period of time.